Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

The study found no link between vitamin D deficiency and psoriasis but suggests more research is needed.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

A new hydrogel with stem cells from human umbilical cords improves skin wound healing and reduces inflammation.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

COVID-19 infection may trigger alopecia areata in some patients.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.